Abstract:The persistence of a reservoir of latently infected CD4 T cells remains one of the major obstacles to cure HIV. Numerous strategies are being explored to eliminate this reservoir. To translate these efforts into clinical trials, there is a strong need for validated biomarkers that can monitor the reservoir over time in vivo. A comprehensive study was designed to evaluate and compare potential HIV-1 reservoir biomarkers. A cohort of 25 patients, treated with suppressive antiretroviral therapy was sampled at three time points, with median of 2.5 years (IQR: 2.4-2.6) between time point 1 and 2; and median of 31 days (IQR: 28-36) between time point 2 and 3. Patients were median of 6 years (IQR: 3-12) on ART, and plasma viral load (<50 copies/ml) was suppressed for median of 4 years (IQR: 2-8). Total HIV-1 DNA, unspliced (us) and multiply spliced HIV-1 RNA, and 2LTR circles were quantified by digital PCR in peripheral blood, at 3 time points. At the second time point, a viral outgrowth assay (VOA) was performed, and integrated HIV-1 DNA and relative mRNA expression levels of HIV-1 restriction factors were quantified. No significant change was found for long- and short-term dynamics of all HIV-1 markers tested in peripheral blood. Integrated HIV-1 DNA was associated with total HIV-1 DNA (p<0.001, R² = 0.85), us HIV-1 RNA (p = 0.029, R² = 0.40), and VOA (p = 0.041, R2 = 0.44). Replication-competent virus was detected in 80% of patients by the VOA and it correlated with total HIV-1 DNA (p = 0.039, R² = 0.54). The mean quantification difference between Alu-PCR and VOA was 2.88 log10, and 2.23 log10 between total HIV-1 DNA and VOA. The levels of usHIV-1 RNA were inversely correlated with mRNA levels of several HIV-1 restriction factors (TRIM5α, SAMHD1, MX2, SLFN11, pSIP1). Our study reveals important correlations between the viral outgrowth and total and integrated HIV-1 DNA measures, suggesting that the total pool of HIV-1 DNA may predict the size of the replication-competent virus in ART suppressed patients.

Current approaches to assess HIV-1 persistence

Translational eradication approaches

New Frontiers in Measuring and Characterizing the HIV Reservoir

Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise

The multifaceted nature of HIV tissue reservoirs

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection

Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure

Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth

A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir

HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

[Research advances in evaluation and measurement techniques of latent human immunodeficiency virus reservoirs]

Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy

Targeting HIV persistence in the tissue

Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human Alu Repeat Sequences

Quantifying the HIV reservoir with dilution assays and deep viral sequencing

Persistent HIV-1 transcription during ART: time to reassess its significance?

Research progress on measuring the latent reservoir of human immunodeficiency virus

Research progress on human immunodeficiency virus reservoir and its eradication

Advanced Therapies for Human Immunodeficiency Virus

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART